Metagenomi Inc (MGX) USD0.0001

Sell:$1.50Buy:$1.51$0.10 (5.94%)

NASDAQ:0.72%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.50
Buy:$1.51
Change:$0.10 (5.94%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$1.50
Buy:$1.51
Change:$0.10 (5.94%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Key people

Brian C. Thomas
Chairman of the Board, Chief Executive Officer, Co-Founder
Jian Irish
President, Chief Operating Officer, Director
Pamela M. Wapnick
Chief Financial Officer
Matthew L. Wein
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Sarah B. Noonberg
Chief Medical Officer
Willard H. Dere
Lead Independent Director
Sebastian Bernales
Independent Director
Eric H. Bjerkholt
Independent Director
Juergen Eckhardt
Independent Director
Click to see more

Key facts

  • EPIC
    MGX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US59102M1045
  • Market cap
    $59.81m
  • Employees
    202
  • Shares in issue
    37.38m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.